학술논문

Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling-informed personalized monitoring assay.
Document Type
Article
Source
Frontiers in Oncology; 2023, p1-11, 11p
Subject
BLADDER cancer
CANCER invasiveness
TRANSITIONAL cell carcinoma
CIRCULATING tumor DNA
LEUCOCYTES
UROTHELIUM
CYSTOTOMY
KIDNEY pelvis
Language
ISSN
2234943X
Abstract
Copyright of Frontiers in Oncology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)